Skip to main content

Table 5 Expression of the miR-17-92 cluster and paralogues in triple-negative tumors compared to others, using microarray

From: Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study

MiRNA

Triple-negative tumors

Not triple-negative tumors

logFC

p*

Mean

SD

Mean

SD

miR-17-5p

6.80

1.10

6.22

0.50

0.581

0.0029

miR-20a-5p

7.16

1.05

6.60

0.42

0.566

0.0021

miR-92a-3p

7.55

0.75

7.17

0.44

0.384

0.011

miR-106b-5p

6.84

0.72

6.50

0.45

0.341

0.021

miR-93-5p

7.23

0.76

6.96

0.51

0.270

0.094

miR-25-3p

6.66

0.41

6.51

0.31

0.147

0.10

  1. Expression levels are given as the mean (standard deviation) of log2 transformed intensity values (Hy3) by microarray analyses
  2. * False discovery rate (FDR) adjusted p-value